Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Monday, July 28, 2025

Distal Ischemic Stroke Treatment With Adjustable Low-profile Stentriever

 From the start you can see that the stroke medical world has the wrong goals for research! Restoring blood flow IS NOT THE SURVIVORS PRIMARY GOAL! 100% RECOVERY IS!

As you can see the stroke medical world has NO understanding of how to run the business of stroke recovery!

Distal Ischemic Stroke Treatment With Adjustable Low-profile Stentriever


ClinicalTrials.gov ID NCT05152524
 Sponsor Rapid Medical 
Information Provided by 
Study Start (Actual)2022-03-25 
Primary Completion (Estimated) 2025-11 
Study Completion (Estimated)2026-01 
Enrollment (Estimated)168
Study TypeInterventional
Last Update Posted2025-07-23

Study Overview

Brief Summary

The objective of the DISTALS Study is to evaluate the safety and effectiveness of the Tigertriever 13 Revascularization Device in restoring blood flow in the neurovasculature by removing thrombus in patients presenting within 24 hours of onset with an ischemic stroke with disabling neurological deficits due to a primary distal vessel occlusion (DVO), as compared to medical management.ClinicalTrials.gov

No comments:

Post a Comment